Skip to content. | Skip to navigation

Personal tools

Home > Medical Center > Department Resources > Clinical Practice Guidelines, Protocols & Pathways > Clinical Practice Guidelines > Wound Biodebridement Guideline - Maggot Debridement Therapy

guideline 2.290 : Wound Biodebridement Guideline - Maggot Debridement Therapy

For carefully selected Adult Acute / Critical Care patients, Maggot Debridement Therapy (MDT) using Phaenicia sericata larvae (maggots) is an acceptable wound care option that may facilitate more rapid debridement to promote wound healing than available alternatives. MDT shall be employed only when more conventional methods including excisional, mechanical, autolytic, and enzymatic debridement are inappropriate or deemed ineffective for an individual patient. [contact Karie Wilson]

File Attachment Downloads

view  |  PDF document icon 2.290_WoundBiodebridementGuideline.pdf — PDF document, 137 KB (140756 bytes)


  1. effective date:

    04/01/2015
nav - root (DO NOT EDIT)